KZIA - Kazia Therapeutics Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 5/24/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.76
52-Week Change 3-15.12%
S&P500 52-Week Change 35.46%
52 Week High 39.7400
52 Week Low 32.2400
50-Day Moving Average 32.7862
200-Day Moving Average 33.7370

Share Statistics

Avg Vol (3 month) 333.24k
Avg Vol (10 day) 319.91k
Shares Outstanding 57.22M
Float 4.02M
% Held by Insiders 10.00%
% Held by Institutions 13.56%
Shares Short (Apr 29, 2020) 4910
Short Ratio (Apr 29, 2020) 40.07
Short % of Float (Apr 29, 2020) 4N/A
Short % of Shares Outstanding (Apr 29, 2020) 40.04%
Shares Short (prior month Mar 30, 2020) 42.63k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jul 13, 2017

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 29, 2019
Most Recent Quarter (mrq)Dec 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.94%
Return on Equity (ttm)-66.12%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-18.60%
Gross Profit (ttm)1.54M
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.9200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.44
Book Value Per Share (mrq)2.94

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A